Title	Publication Date	Language	Citations
Monotherapy with Lopinavir/Ritonavir as Maintenance After HIV-1 Viral Suppression: Results of a 96-Week Randomized, Controlled, Open-Label, Pilot Trial (KalMo Study)	2009/12/01	English	41
Antiretroviral Treatment Regimen Outcomes Among HIV-Infected Prisoners	2007/08/01	English	41
Effects of First-Line Use of Nucleoside Analogues, Efavirenz, and Ritonavir-Boosted Protease Inhibitors on Lipid Levels	2009/02/01	English	40
The Effects of Exercise Training on Metabolic and Morphological Outcomes for People Living With HIV: A Systematic Review of Randomised Controlled Trials	2010/10/01	English	40
Guidelines on the Treatment of Chronic Coinfection byTrypanosoma cruziand HIV Outside Endemic Areas	2011/12/01	English	39
Improvements in Subcutaneous Fat, Lipid Profile, and Parameters of Mitochondrial Toxicity in Patients with Peripheral Lipoatrophy When Stavudine is Switched to Tenofovir (LIPOTEST Study)	2008/12/01	English	39
HIV-1 resistance rarely observed in subjects using darunavir once-daily regimens across clinical studies	2017/11/02	English	38
Prevalence of Cardiac Diastolic Dysfunction in HIV-Infected Patients: Results of the HIV-HEART Study	2010/06/01	English	37
Renal Toxicity Associated With Antiretroviral Therapy	2012/08/01	English	37
Low Rate of CMV End-Organ Disease in HIV-Infected Patients Despite Low CD4+ Cell Counts and CMV Viremia: Results of ACTG Protocol A5030	2009/06/01	English	36
Development of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials	2010/08/01	English	36
Memantine for AIDS Dementia Complex: Open-Label Report of ACTG 301	2010/02/01	English	35
Virologic, Immunologic, Clinical, Safety, and Resistance Outcomes from a Long-Term Comparison of Efavirenz-Based Versus Nevirapine-Based Antiretroviral Regimens as Initial Therapy in HIV-1—Infected Persons	2008/10/01	English	35
The Incidence of HIV Drug Resistance and Its Impact on Progression of HIV Disease Among Antiretroviral-Naïve Participants Started on Three Different Antiretroviral Therapy Strategies	2007/12/01	English	35
Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial	2011/02/01	English	35
Randomization to Once-Daily Stavudine Extended Release/Lamivudine/Efavirenz Versus a More Frequent Regimen Improves Adherence While Maintaining Viral Suppression	2008/06/01	English	35
Review: Human Immunodeficiency Virus (HIV) and Malaria Interaction in Sub-Saharan Africa: The Collision of Two Titans	2007/08/01	English	35
Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials	2008/06/01	English	34
Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad®Efficacy and Safety (SMiLES)	2010/08/01	English	34
Dolutegravir: Clinical and Laboratory Safety in Integrase Inhibitor–Naive Patients	2014/10/01	English	34
Prevalence and Risk Factors of Prolonged QTc Interval in HIV-Infected Patients: Results of the HIV-HEART Study	2009/08/01	English	33
Pharmacokinetics and Safety of Nelfinavir When Used in Combination with Zidovudine and Lamivudine in HIV-Infected Pregnant Women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353	2008/04/01	English	32
Postpartum Viral Load Rebound in HIV-1–Infected Women Treated with Highly Active Antiretroviral Therapy: AIDS Clinical Trials Group Protocol A5150	2011/02/01	English	32
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study	2017/05/04	English	31
Monthly Unannounced Pill Counts for Monitoring HIV Treatment Adherence: Tests for Self-Monitoring and Reactivity Effects	2010/12/01	English	30
Vitamin D Supplementation Does Not Increase Immunogenicity of Seasonal Influenza Vaccine in HIV-Infected Adults	2011/10/01	English	29
PRO 140, a monoclonal antibody targeting CCR5, as a long-acting, single-agent maintenance therapy for HIV-1 infection	2018/04/20	English	29
Systematic Review and Meta–Analysis of the Diagnostic Accuracy of Fibrosis Marker Panels in Patients with HIV/Hepatitis C Coinfection	2008/02/01	English	29
Safety, Tolerability, and Efficacy of Darunavir (TMC114) with Low-Dose Ritonavir in Treatment-Experienced, Hepatitis B or C Co-infected Patients in POWER 1 and 3	2007/08/01	English	29
Incidence Rate of and Factors Associated with Loss to Follow-up in a Longitudinal Cohort of Antiretroviral-Treated HIV-Infected Persons: An AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) Analysis	2011/08/01	English	28